Tag

Rossari International Company Limited

1 article

Rossari Biotech Q2 PAT Rises 5.5% YoY

Board approved Q2 FY2026 standalone and consolidated unaudited financial results, reporting a consolidated PAT of ₹389.07 million. Approved leasing of land in Saudi Arabia by wholly-owned subsidiary R